TrialShare portal strikes blow for data transparency PharmaTimes ... is debuting its TrialShare portal in conjunction with the publication in the New England Journal of Medicine of 18-month results from the Network's RAVE trial of the B-cell depleting agent rituximab in Wegener's Granulomatosis and Microscopic ... |
